A cheap gout medication, colchicine, shows significant promise in preventing heart attacks and strokes for individuals with ...
A DRUG prescribed to thousands of Brits a could reduce the risk of a heart attack or stroke, according to a new study.
Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular disease. Trials involving nearly 23,000 patients show meaningful reductions in ...
Colchicine, an inexpensive drug used to treat gout, could cut heart attacks and strokes in people with cardiovascular disease ...
For gout pain that does not respond to conventional therapies, patients’ only remaining option is a drug from Amgen. But this biologic medicine introduces the same problem facing every therapeutic ...
A variety of factors, including concomitant medications, increase the risk for adverse events related to colchicine prophylaxis in patients who are starting gout treatment. Investigators conducted a ...
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according ...
The MarketWatch News Department was not involved in the creation of this content. -- Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients ...
Protalix shows mixed financials with declining revenue, yet improved operating loss, indicating increasing operational efficiency. PRX-115, in Phase I trials for refractory gout, is crucial in a ...
Management of a patient allergic to allopurinol can be considered a therapeutic challenge. This article highlights the diversity of medications that can be used to manage hyperuricemia during this ...
Savient Pharmaceuticals of East Brunswick said its gout drug, Puricase (pegloticase), reached its main goal in late-stage trials, achieving statistically significant positive results in the late-stage ...
A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according ...